TNF and neoplasm: Other pathologic factors include the increased levels of inflammatory cytokines such as interleukins (IL-6 and IL-1β) and tumor necrosis factor (TNF-α), both of which contribute to tissue inflammation, tumor invasiveness, and less response to endocrine therapies (Goldberg and Schwertfeger, 2010).